Qingdao Haier Biomedical Co Ltd (688139) — Cash Flow Quality Index
Qingdao Haier Biomedical Co Ltd (688139) has a Cash Flow Quality Index of 0.05x as of June 2023. Operating cash flow of CN¥7.33 Million is below net income of CN¥140.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore balance sheet size of Qingdao Haier Biomedical Co Ltd for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Qingdao Haier Biomedical Co Ltd Cash Flow Quality Index (2016–2025)
Historical Cash Flow Quality Index for Qingdao Haier Biomedical Co Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 688139 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Qingdao Haier Biomedical Co Ltd (2016–2025)
Year-by-year earnings quality comparison for Qingdao Haier Biomedical Co Ltd. For live market cap and the full company financial profile, see 688139 market cap.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.07x | CN¥267.89 Million | CN¥250.73 Million | ▲ +34.3% |
| 2024 | 0.80x | CN¥291.67 Million | CN¥366.63 Million | ▲ +29.6% |
| 2023 | 0.61x | CN¥249.26 Million | CN¥406.07 Million | ▼ -41.7% |
| 2022 | 1.05x | CN¥632.43 Million | CN¥600.79 Million | ▲ +36.2% |
| 2021 | 0.77x | CN¥632.43 Million | CN¥818.33 Million | ▼ -57.7% |
| 2020 | 1.83x | CN¥696.62 Million | CN¥380.95 Million | ▲ +18.7% |
| 2019 | 1.54x | CN¥280.49 Million | CN¥182.06 Million | ▲ +17.8% |
| 2018 | 1.31x | CN¥149.00 Million | CN¥113.96 Million | ▼ -46.8% |
| 2017 | 2.46x | CN¥148.32 Million | CN¥60.39 Million | ▲ +37.1% |
| 2016 | 1.79x | CN¥220.72 Million | CN¥123.21 Million | — |